Search

Displaying results 4801 - 4810 of 6076 in total
  1. Drug

    Iberdomide

    go.drugbank.com/drugs/DB12101
    Investigational

    [L64055,L64056] It is the first cereblon E3 ligase modulator (CELMoD) approved for multiple myeloma.[L64057] … [L64055] The FDA granted iberdomide accelerated approval on August 13, 2026, in combination with daratumumab and hyaluronidase-fihj and dexamethasone for adults with multiple myeloma who have received

  2. Drug

    BACTEK-R

    go.drugbank.com/drugs/DB16526
    Investigational

    MV130 contains different components of whole heat-inactivated gram-positive and -negative bacteria that are involved in upper and lower respiratory infections. These include streptococcus pneumoniae and staphylococcus aureus. Though stud...

  3. Drug

    Pam2csk4

    go.drugbank.com/drugs/DB16474
    Investigational

    Categories: Experimental Unapproved Treatments for COVID-19
  4. Drug

    NP-50301

    go.drugbank.com/drugs/DB05662
    Experimental

    It is estimated that about 30% of postmenopausal women suffer symptoms of DES, which accounts for over 12 million women in the U.S.

  5. Drug

    Oglufanide

    go.drugbank.com/drugs/DB05779
    Investigational

    Oglufanide is a synthetic dipeptide immunomodulator in development for the treatment of chronic hepatitis C viral infection.

  6. Drug

    Meladrazine

    go.drugbank.com/drugs/DB13272
    Experimental

    Categories: Drugs for Urinary Frequency and Incontinence
  7. Drug

    Quifenadine

    go.drugbank.com/drugs/DB13713
    Experimental

    Categories: Antihistamines for Systemic Use
  8. Drug

    Cadexomer iodine

    go.drugbank.com/drugs/DB16572
    Investigational

    Categories: Preparations for Treatment of Wounds and Ulcers
  9. Drug

    Benzilone

    go.drugbank.com/drugs/DB13369
    Experimental

    Categories: Drugs for Functional Gastrointestinal Disorders
  10. Drug

    Quinbolone

    go.drugbank.com/drugs/DB13484
    Experimental

    Categories: Anabolic Agents for Systemic Use